Atorvastatin Calcium
Product Images NDC 68071-2680

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2680). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2680 9)

Pdp (68071 2680 9)
NuCare Pharmaceuticals, Inc. is a drug manufacturer. The product being described is Atorvastatin Calcium 40mg tablets, with NDC 68071-2680-09 and lot number 00000. The tablets come in a bottle of 90 tablets and are only available with a prescription. The manufacturers' label includes a GTIN code of 0038807126809. This drug should be kept out of reach of children and stored at a controlled temperature between 68-77°F. For more information, consumers should contact their physician or call 1-800-FDA-1088.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

Figure (Atorvastatin Calcium Figure 2)
This appears to be a graph or chart displaying the cumulative hazard percentage of a placebo and a medication called Atorvastatin over four years of follow-up. The medication has a lower hazard ratio than the placebo, indicating a potentially lower risk of the primary endpoint.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

Figure (Atorvastatin Calcium Figure 3)
This is a statistical report on a study of the effects of Atorvastatin, a medication used to lower cholesterol levels, on the occurrence of major cardiovascular events. The percentages of subjects experiencing events are not provided, instead the chart shows a HR=0.78 (0.69-0.89) with a p-value of 0.0002 for Atorvastatin 80mg, indicating a reduction in the risk of experiencing major cardiovascular events. The chart also shows the time it takes for the subjects to experience the first major cardiovascular endpoint, in years, numbered 1 to 5.*
FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.